Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 March 2007

A Quantitative review of the use of FDG-PET in the axillary staging of breast cancer

J Scott Sloka, Peter D Hollett, Maria Mathews

Med Sci Monit 2007; 13(3): RA37-46 :: ID: 475679

Abstract

Breast cancer is the most frequent type of cancer in women and is the second leading cause of cancer death in Canadian women. It is an important source of morbidity and mortality in today’s society and confers risk to the patient both in terms of the disease itself and the treatment of the disease. Axillary lymph node status is the most important prognostic factor for determining breast cancer survival and it guides the treatment of the disease based on the disease stage. The aim of this study is to assess the diagnostic value of positron emission tomography (PET) utilizing [18F]2-fl uoro-2-deoxy-D-glucose (FDG) in the axillary staging of breast cancer. A systematic literature search was carried out in the Medline, Embase and Cochrane databases. Seventy one original studies were identifi ed, 20 of which evaluated the axillary status of women. The studies were graded based on recommended procedures from similar studies. Aggregate sensitivities and specifi cities were calculated for various levels of quality for all included studies. Recommendations for future studies were made based on patient positioning, acquisition time, attenuation correction, fasting state, and image interpretation. A large variation in the sensitivity and specifi city of large diagnostic trials of similar quality was noted. We concluded that PET has promise for the axillary staging of breast cancer once the variability of sensitivity and specifi city in these large trials is addressed.

Keywords: Breast Neoplasms - pathology, Axilla, Fluorodeoxyglucose F18 - diagnostic use, Lymph Nodes - pathology, Positron-Emission Tomography

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750